Pharmaceutical Research banner
  • "A comparative assessment of current and future pharmacovigilance in developed and developing countries - A case study of Ireland and Nigeria" by OLANREWAJU JIMOH

    MR OLANREWAJU JIMOHMedicine majorly constitutes the use of prescribing and administering drugs by healthcare professionals majorly the pharmacist and the medical doctors. The importance of these two professions is very paramount in fighting diseases and promoting good healthcare as well as the general well-being of humans. Also, the current drug discovery and research within the pharmaceutical industry have led to the will for the need for the safety and efficacy of drug products. The safety of the drug has been a major concern aftermarket authorization due to limited clinical trials which cannot prove the safety of the public health after consumption. Adverse drug reaction has always been a major challenge in the life of drug users and this cannot be avoided but rather can be prevented. The standard clinical trial phases include phase 1 which usually comprises a certain number of humans, mostly less than 20, and their safety with a lesser dosage of the drug, phase 2 is 50 to 100 towards the adequate dosage specifications. Phase 3 is usually carried towards a specific condition at which the drug is being produced for the effectiveness in treating a certain condition while phase 4 is conducted to identify the long term effects of the drug after the approval and enters the market. All these phases have led to pharmacovigilance activities of ADR reporting on how drug products are working after taking and the safety of the people using it.

    Read more/less

     

     Objectives:

    The thesis objectives are to compare and evaluate the factors about reporting Adverse Drug Reactions in the developed and developing countries among healthcare professionals (Medical doctors and Pharmacists) using Ireland and Nigeria as a case study.

    Methodology:

    A questionnaire survey and phone interviews for quantitative and qualitative analysis are carried out respectively within the two regions (Ireland and Nigeria). The challenges faced by medical professionals concerning ADR reporting are achieved based on their knowledge and awareness to determine an effective recommendation to help improve both regions using the comparison results and works of literature gathered.

     
    Findings:

    An Overall total of 122 respondents from both Nigeria and Ireland are received which consists of 47 respondents from Ireland (12 medical doctors and 35 pharmacists) and 75 respondents from Nigeria (32 medical doctors and 43 pharmacists) showing a response rate of 60.0% and 87.5% from 20 and 45 medical doctors and pharmacist from Ireland and response rate of 71.1% and 95.5% out of 45 respondents respectively from both medical doctors and pharmacist from Nigeria. Surprisingly, 98.0% of the correspondents which consist of 12 medical doctors and 35 pharmacists from Ireland responded to knowing how to report ADRs to compare to 71.0% from Nigeria which is quite above average consisting of 26 medical doctors and 27 pharmacists responded to knowing how ADRs is being reported. However, it shows that pharmacists had better knowledge, awareness, understanding, and experience over the medical doctors regarding ADRs reporting. However, 92.0% and 96.0% of respondents of both groups from Nigeria and Ireland respectively opted to ADR reporting being made compulsory as a professional obligation towards achieving and improving pharmacovigilance.
     
    Analysis:

    It shows that the challenges affecting ADR reporting in Nigeria are associated with the inaccessibility of ADR report forms when needed, complex reporting processes while too busy and lack of time remained the most common challenging factor among this too regions. The least common challenges reported at both regions are level of clinical trial knowledge, a concern that ADR report mighty is wrong among, fear of legal liabilities, and fear of exposure to legal liabilities from patient or drug manufacturer.

    Conclusions:

    Proper comparison and recommendation from both sides from the country shows the need for better improvement in awareness among healthcare professionals in Nigeria been the country with the highest level of challenges compare to their counterpart healthcare professionals and this could be achieved by organizing pharmacovigilance conferences, continuous education programs included in their professional courses and training to improve knowledge of ADR reporting. Establishment of ADR departments in healthcare institutions headed by ADR specialists and offering professional recognition rather than financial rewards are the sustainable recommendation to put in practice in both regions to further improve the practice of ADR reporting in Nigeria and Ireland. To wrap it up, the need for the regulatory bodies from the developing countries to work in hand with the developed countries to better improves awareness, knowledge, and improvement towards ADRs reporting system.

  • "Challenges impacting the reporting of Adverse Drug Reactions among healthcare professionals: Improving pharmacovigilance in Nigeria." by Dr. Prosper Chibuikem Anaedu

    ProsperAn ADR is a drug response that is unintended and occurs at doses normally used in man for prophylaxis, therapy or the modification of physiological function. ADR reporting is critical in improving pharmacovigilance in Nigeria. This oversees the activities that relates to the knowledge, detection, assessment and prevention of adverse events or any drug-related issue. This research was undertaken with the purpose of identifying and exploring the challenges faced by healthcare professionals in spontaneously reporting ADRs, with the aim of improving reporting rates, promoting drug safety practices and reducing the burden of ADRs in Nigeria. Issues emanating from ADRs are highly critical because of the drug misinformation, misuse, advanced age-related physiological, biological, pharmacokinetic and pharmacodynamic changes observed. When patients suffer from ADRs, it is challenging to determine how severe the outcomes are, even when the prescribed drug benefits clearly outweigh the risks.

     

    Read more/less

     Objectives:

    The author explored the knowledge, attitude and experience of ADR spontaneous reporting among medical doctors and pharmacists in line with established guidelines and regulations by the relevant authorities in Nigeria. Although current spontaneous reporting practices are less than optimal, this research dissertation was aimed at articulating effective strategies that could be optimally leveraged to improve the frequency and quality of reporting while driving better positive health outcomes for patients across Nigeria. An outline of the research objectives include:

    1. To evaluate the knowledge and awareness of ADR reporting among healthcare professionals in Nigeria

    2. To assess challenges among healthcare professionals in the practice of ADR reporting in Nigeria.

    3. To make sustainable recommendations to improve ADR reporting among healthcare professionals in Nigeria.

    Methodology:

    Primary and secondary research methods were utilised by the author through the electronic dissemination of questionnaires, phone interviews and literature reviews. The secondary research was first carried out to explore relevant current literature from reputable research databases and journals on ADR reporting to determine the gaps as it pertains to the established research objectives. Attempts to fill these gaps were subsequently carried out through primary research by distributing questionnaires to 140 medical doctors and pharmacists (74.3% response rate), which constituted the approach for quantitative analysis. Phone interviews were further conducted for qualitative analysis with 10 highly experienced healthcare professionals (over 10 years of experience). The author applied the positivism and interpretivism philosophies to analyse the questionnaire and phone interview findings respectively.

     
     
     
     

    Findings:

    Both groups of healthcare professionals were compared to determine their opinions on frequency of observed and reported ADRs, reasons for high underreporting rates, awareness of ADR reporting methods, guidelines and regulations as well as the NAFDAC regulatory body responsible for handling submitted ADR reports. A total of 104 out of 140 responded to the survey, of whom 53 (75.7%) were medical doctors and 51 (72.9%) were pharmacists. 34.0% of medical doctors who responded did not know how to report ADRs compared to just 5.9% of pharmacists who responded. In ascertaining familiar ADR reporting method, 39.0% of respondents selected yellow cards/ADR forms, 11.0% of respondents selected the ADR e-reporting form while 25.0% of respondents were familiar with both methods. 25.0% of respondents were unfamiliar with any of the methods for reporting ADRs in Nigeria. 36.0% of respondents admitted having reported an ADR within the past 12 months. The majority 57.0% of respondents indicated not to have reported an ADR in the past 12 months while 7.0% of respondents were unsure if they did. An overwhelming 90.0% of respondents opted for ADR reporting being made compulsory as a professional obligation towards pharmacovigilance.

    Analysis:

    Analysis showed that medical doctors and pharmacists have only an average knowledge and awareness of ADR reporting in Nigeria. They can correctly identify ADRs and the criteria for reporting but effective reporting remains a challenge. Pharmacists had better knowledge, awareness and experience over medical doctors regarding ADR reporting in Nigeria. However, despite overall poor attitudes to reporting ADRs, both groups exhibited a willingness to do better if proper continuous education and training is made available. NAFDAC performed poorly in raising awareness, providing training and encouraging better drug safety practices and pharmacovigilance. Very few healthcare professionals are aware of the guidelines or regulations governing the ADR reporting system in Nigeria. The authorities rarely acknowledge or follow up on reported ADRs which results in poor reporting rates. Factors varied among both groups as the challenges faced by medical doctors does not translate to the same challenge faced by pharmacists. However, both groups of HCPs agree that ADR reporting should be made a professional obligation to improve ADR reporting in Nigeria. Despite an overwhelming acceptance of the authors' recommendations, some opposed extra remunerations for every ADR reports made as it might distract from the ideal purpose of ADR reporting and pharmacovigilance- improving drug and patient safety in Nigeria.

    Conclusions:

    Factors ranging from indifference to ADR reporting, poor knowledge and accessibility of reporting methods, poor awareness of guidelines surrounding the reporting procedures are to great extent the same as observed from other studies in Nigeria and other countries. While few studies on ADR reporting in Nigeria compare multiple groups of healthcare professionals, this study demonstrates that pharmacists are more predisposed to favorable outcomes regarding ADR reporting than their medical doctor counterparts. Improving ADR reporting in Nigeria would greatly reduce the healthcare costs and mortality rates and further reduce the incidence of ADRs observed. As suggested by both groups of healthcare professionals, a review of regulations to make ADR reporting compulsory as a professional obligation towards patient safety bears great potential. The course content of the medical and pharmaceutical students should be reviewed to include modules on ADR reporting and tutorials on pharmacovigilance and drug safety practices prior to graduation. Health institutions should establish ADR departments headed by ADR specialists to improve reporting rates in Nigeria and foster liaison with the National Pharmacovigilance centers.


  • "Enhancing pharmacovigilance in Nigeria: Challenges faced by NAFDAC in monitoring of Adverse Drug Reactions in Nigeria." by Chinedum Odigbo

    Moyosore Oluwatoyosi OsokoNigeria, for a long have time been characterised by challenges in the medical sphere. This has given rise to increased mortality and morbidity rates in Nigeria. Apart from the challenges faced, there exists a low level of monitoring of adverse drug reactions. Drugs being authorised into the market are scarcely monitored to ascertain if there exist other side effects not observed in the clinical trials. Regulatory agency(NAFDAC) responsible for monitoring of drugs in the post-market authorisation period have not been effective in the dispensing of their duties which has contributed to the increased rate of mortality and morbidity in Nigeria.


    Read more/less

     

     Objectives:

    1. To determine if NAFDAC possesses the capability to monitor and address reported ADR cases.

    2. To identify the factors that hinder NAFDAC from effectively monitoring ADR in Nigeria.

    3. To proffer solutions that will help boost ADR monitoring by NAFDAC.

    Methodology:

    RESEARCH APPROACH: Quantitative
    RESEARCH METHODS: Descriptive research method.
    RESEARCH PHILOSOPHY: Positivism.
    PROBABILITY SAMPLING: Simple random sampling method.
    SAMPLE SIZE DETERMINATION: Cochran’s formula was adopted.
    METHODS OF DATA COLLECTION: Primary research was used.
    RESEARCH INSTRUMENT: Close-ended electronic survey questionnaire.
    VALIDITY OF THE RESEARCH INSTRUMENT: Face validity and content validity
    RELIABILITY OF THE RESEARCH INSTRUMENT: Cronbach’s alpha coefficient was used.
    METHOD OF DATA ANALYSIS: Statistical Package for Social Sciences using descriptive statistics.
    ACCESS & ETHICAL CONSIDERATION: Participants were given the free will to decide to participate in the study or not, were duly informed about keeping their identities hidden and information confidential.
     
    Findings:

    As revealed by the research findings, one of the challenges affecting NAFDAC’s effective monitoring of ADR is the inconsistent training of staff on latest developments in ADR monitoring. Not keeping staff abreast with recent developments in the monitoring of ADRs is a significant factor that hinders the effective practice of ADR monitoring by the regulatory agency. As a result, regular trainings where staff’s knowledge are updated with current trends with respect to ADR monitoring should be conducted. It is without doubt that ADR monitoring stems from the reporting of ADRs. One of the factors limiting NAFDAC’s ineffective monitoring of ADR is the reluctance of medical practitioners and consumers to report ADR cases. And the when ADR cases are not reported, the practice of monitoring cannot be carried out.
     
    Analysis:

    The analysis of this study have revealed that most NAFDAC staff understand the concept of ADR monitoring.This has provided the study with a solid foundation for answering its research questions because responses given by the study’s participants can be trusted due to their understanding of the study’s main subject matter – ADR monitoring. It was discovered from the analysis that monitoring of ADRs would impact positively on the safety of public health and that a positive relationship exists between ADR monitoring and reduction in ADR cases. These findings reveal the significant role ADR monitoring plays in safeguarding the public health of the people of a nation. In the health sector of every nation, it is advisable for ADR monitoring to be taken seriously due to the significant role it plays in protecting the strength of a nation.

    Conclusions:

    The researcher concludes that of a truth the Nigerian regulatory agency, NAFDAC has the capability to effectively monitor and address ADR issues but that attention should be given to the use of technological solutions in the carrying out of ADR monitoring practices as seen in Kenya. This would in turn increase the agency’s effectiveness in the monitoring of ADRs in the nation. Moreover, the staff revealed some other factors that hinder the effective monitoring of ADRs by NAFDAC. These factors include; poor and inconsistent training of staff, poor administration of the agency, corruption and conflict of interest, lack of qualified manpower, reluctance of most healthcare professionals to report ADR issues, and consumers who refuse to report ADR experiences after consumption of a drug.

© 2018 Innopharma. All rights reserved.

PrivacyTerms of UseHome